<--- Back to Details
First PageDocument Content
Chemistry / Medicine / Clinical medicine / Excipients / Inborn errors of purine-pyrimidine metabolism / Uric acid / Biotechnology / PEGylation / Pharmacokinetics / Pegloticase / Urate oxidase / Polyethylene glycol
Date: 2016-07-11 16:49:52
Chemistry
Medicine
Clinical medicine
Excipients
Inborn errors of purine-pyrimidine metabolism
Uric acid
Biotechnology
PEGylation
Pharmacokinetics
Pegloticase
Urate oxidase
Polyethylene glycol

Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 589,61 KB

Share Document on Facebook

Similar Documents

Microsoft Word - FDA Grants Priority Review to Pegloticase BLA Filingdoc

Microsoft Word - FDA Grants Priority Review to Pegloticase BLA Filingdoc

DocID: 1sopU - View Document

Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1
               Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1

Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1

DocID: 1rrGr - View Document

Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1
               Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1

Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1

DocID: 1rrm1 - View Document

Microsoft Word - Savient Press Release ACRdoc

Microsoft Word - Savient Press Release ACRdoc

DocID: 1rrcY - View Document

Microsoft Word - Savient Phase 3 Dosing press releasedoc

Microsoft Word - Savient Phase 3 Dosing press releasedoc

DocID: 1ri7E - View Document